{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T21:08:12Z","timestamp":1778965692466,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016145","name":"Ministerio de Sanidad, Consumo y Bienestar Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.eimce.2025.06.012","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:30:52Z","timestamp":1759343452000},"page":"515-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SIPrEP: A tool to monitor HIV pre-exposure prophylaxis in Spain"],"prefix":"10.1016","volume":"43","author":[{"given":"Carlos","family":"Iniesta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Hernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inma","family":"Jarr\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"P\u00e9rez de la C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"De la Torre-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicent","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa Isabel","family":"Mayorga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Belda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maribel","family":"Soteras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Torres Lana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aitziber","family":"Echeverria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Monteagudo-Piqueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henar","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafa","family":"Ben Cheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n-Alexander","family":"Portocarrero-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora","family":"\u00c1lvarez-del Arco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"del Amo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2025.06.012_bib0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eimce.2025.06.012_bib0210","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2025.06.012_bib0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(17)30540-6","article-title":"Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation","volume":"18","author":"Cambiano","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimce.2025.06.012_bib0220","doi-asserted-by":"crossref","first-page":"1800398","DOI":"10.2807\/1560-7917.ES.2019.24.7.1800398","article-title":"Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058","volume":"24","author":"van de Vijver","year":"2019","journal-title":"Euro Surveill"},{"key":"10.1016\/j.eimce.2025.06.012_bib0225","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/cid\/ciz1229","article-title":"Evidence of an association of increases in pre-exposure prophylaxis coverage with decreases in human immunodeficiency virus diagnosis rates in the United States, 2012\u20132016","volume":"71","author":"Smith","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2025.06.012_bib0230","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/S2352-3018(18)30215-7","article-title":"Population-level effectiveness of rapid targeted high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study","volume":"5","author":"Grulich","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eimce.2025.06.012_bib0235","year":"2024"},{"key":"10.1016\/j.eimce.2025.06.012_bib0240","unstructured":"HIV Prevention 2020 Road Map \u2013 accelerating HIV prevention to reduce new infections by 75% [Internet]. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2017\/hiv-prevention-2020-road-map [cited 21 November 2024]."},{"key":"10.1016\/j.eimce.2025.06.012_bib0400","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.rce.2019.02.001","article-title":"Implementing pre-exposure prophylaxis could prevent most new HIV infections in transsexual women and men who have sex with men","volume":"219","author":"Ayerdi Aguirrebengoa","year":"2019","journal-title":"Rev Clin Esp (Barc)."},{"key":"10.1016\/j.eimce.2025.06.012_bib0250","series-title":"Ministerio de Sanidad Manual de implementaci\u00f3n de un Programa de Profilaxis Preexposici\u00f3n al VIH en Espa\u00f1a","author":"Grupo de Trabajo de PrEP","year":"2021"},{"key":"10.1016\/j.eimce.2025.06.012_bib0255","doi-asserted-by":"crossref","first-page":"e0246129","DOI":"10.1371\/journal.pone.0246129","article-title":"Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models","volume":"16","author":"Iniesta","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.eimce.2025.06.012_bib0260","series-title":"Pre-exposure prophylaxis for HIV prevention in Europe [Internet]","year":"2016"},{"key":"10.1016\/j.eimce.2025.06.012_bib0265","unstructured":"WHO PrEP Implementation Tool [Internet]. Available from: https:\/\/www.who.int\/tools\/prep-implementation-tool [cited 21 November 2024]."},{"key":"10.1016\/j.eimce.2025.06.012_bib0270","series-title":"Sistema de informaci\u00f3n de programas de Profilaxis Pre-exposici\u00f3n al VIH en Espa\u00f1a (SIPrEP). Informe de resultados noviembre 2019-mayo 2024","year":"2024"},{"key":"10.1016\/j.eimce.2025.06.012_bib0275","unstructured":"Spain-National-PrEP-Guideliens-2020.pdf [Internet]. Available from: https:\/\/www.prepwatch.org\/wp-content\/uploads\/2022\/03\/Spain-National-PrEP-Guideliens-2020.pdf [cited 21 November 2024]."},{"key":"10.1016\/j.eimce.2025.06.012_bib0280","series-title":"Prevention of HIV in \u201c\u00cele-de-France\u201d \u2013 full text view \u2013 ClinicalTrials, gov. Report No.: NCT03113123","year":"2022"},{"key":"10.1016\/j.eimce.2025.06.012_bib0285","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1016\/S2352-3018(23)00256-4","article-title":"HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment","volume":"10","author":"Sullivan","year":"2023","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eimce.2025.06.012_bib0290","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.eimc.2011.06.002","article-title":"La cohorte de la red espa\u00f1ola de investigaci\u00f3n en sida y su biobanco: organizaci\u00f3n, principales resultados y p\u00e9rdidas al seguimiento","volume":"29","author":"Sobrino-Vegas","year":"2011","journal-title":"Enferm Infecc Microbiol Cl\u00edn"},{"key":"10.1016\/j.eimce.2025.06.012_bib0295","doi-asserted-by":"crossref","first-page":"e25105","DOI":"10.1002\/jia2.25105","article-title":"Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam","volume":"21","author":"Hoornenborg","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.eimce.2025.06.012_bib0300","doi-asserted-by":"crossref","first-page":"e028768","DOI":"10.1136\/bmjopen-2018-028768","article-title":"Cohort profile: l\u2019Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada","volume":"9","author":"Greenwald","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.eimce.2025.06.012_bib0305","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1007\/s10461-018-2045-1","article-title":"Quit pre-exposure prophylaxis (PrEP)? A mixed-method study exploring reasons for PrEP discontinuation and potential re-initiation among gay and bisexual men","volume":"22","author":"Whitfield","year":"2018","journal-title":"AIDS Behav"},{"key":"10.1016\/j.eimce.2025.06.012_bib0315","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/jac\/dkae133","article-title":"Incidence and factors associated with PrEP discontinuation in France","volume":"79","author":"Garofoli","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2025.06.012_bib0320","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12889-021-10174-4","article-title":"Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany","volume":"21","author":"Koppe","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.eimce.2025.06.012_bib0325","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/QAI.0000000000003010","article-title":"Brief report: previous preexposure prophylaxis use among men who have sex with men newly diagnosed with HIV infection in King County, WA","volume":"90","author":"Cannon","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimce.2025.06.012_bib0330","doi-asserted-by":"crossref","first-page":"102647","DOI":"10.1016\/j.eclinm.2024.102647","article-title":"Restarting pre-exposure prophylaxis (PrEP) for HIV: a systematic review and meta-analysis","volume":"72","author":"Kiggundu","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.eimce.2025.06.012_bib0405","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/apc.2021.0197","article-title":"Why do HIV pre-exposure prophylaxis users discontinue pre-exposure prophylaxis care? A mixed methods survey in a pre-exposure prophylaxis clinic in Belgium","volume":"36","author":"Vanbaelen","year":"2022","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.eimce.2025.06.012_bib0335","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0000000000002952","article-title":"Reasons for PrEP discontinuation after navigation at sexual health clinics: interactions among systemic barriers, behavioral relevance, and medication concerns","volume":"90","author":"Unger","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimce.2025.06.012_bib0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/QAI.0000000000001164","article-title":"Brief report: PrEP uptake adherence, and discontinuation among California YMSM using geosocial networking applications","volume":"74","author":"Holloway","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimce.2025.06.012_bib0345","doi-asserted-by":"crossref","first-page":"e2122692","DOI":"10.1001\/jamanetworkopen.2021.22692","article-title":"Characterization of HIV preexposure prophylaxis use behaviors and HIV incidence among US adults in an integrated health care system","volume":"4","author":"Hojilla","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.eimce.2025.06.012_bib0350","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S2352-3018(19)30136-5","article-title":"Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study","volume":"6","author":"Hoornenborg","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eimce.2025.06.012_bib0355","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/jac\/dkab263","article-title":"PrEP monitoring and HIV incidence after PrEP initiation in France: 2016\u201318 nationwide cohort study","volume":"76","author":"Tassi","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2025.06.012_bib0360","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/QAI.0000000000002186","article-title":"Brief report: incidence of HIV in a nationwide cohort receiving pre-exposure prophylaxis for HIV prevention","volume":"82","author":"Van Epps","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimce.2025.06.012_bib0365","first-page":"1","article-title":"How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR study","volume":"16","author":"Puppo","year":"2020","journal-title":"AIDS Care"},{"key":"10.1016\/j.eimce.2025.06.012_bib0370","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/QAI.0000000000001251","article-title":"Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States","volume":"74","author":"Parsons","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Supplement_4","key":"10.1016\/j.eimce.2025.06.012_bib0375","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckz185.355","article-title":"PrEP users among Lisbon MSM Cohort participants \u2013 a first look after PrEP implementation in Portugal","volume":"29","author":"Fernandes","year":"2019","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.eimce.2025.06.012_bib0380","series-title":"Implementation of HIV PrEP in Scotland: second year report","year":"2019"},{"key":"10.1016\/j.eimce.2025.06.012_bib0385","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.2196\/publichealth.7902","article-title":"Developing a web-based geolocated directory of HIV pre-exposure prophylaxis-providing clinics: the PrEP locator protocol and operating procedures","volume":"3","author":"Siegler","year":"2017","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.eimce.2025.06.012_bib0390","doi-asserted-by":"crossref","first-page":"106962","DOI":"10.1016\/j.ypmed.2022.106962","article-title":"Would eligible gay, bisexual and other men who have sex with men use PrEP? Awareness, knowledge, eligibility and intention to use PrEP among EMIS-2017 participants in Spain","volume":"156","author":"Iniesta","year":"2022","journal-title":"Prev Med"},{"key":"10.1016\/j.eimce.2025.06.012_bib0395","doi-asserted-by":"crossref","first-page":"107017","DOI":"10.1016\/j.ypmed.2022.107017","article-title":"Corrigendum to \u201cWould eligible gay, bisexual and other men who have sex with men use PrEP? Awareness, knowledge, eligibility and intention to use PrEP among EMIS-2017 participants in Spain\u201d [Prev Med 156 (2022) 106962]","volume":"157","author":"Iniesta","year":"2022","journal-title":"Prev Med"},{"key":"10.1016\/j.eimce.2025.06.012_bib0410","unstructured":"GeSIDA. Recomendaciones sobre la Profilaxis Pre-Exposici\u00f3n para la Prevenci\u00f3n de la Infecci\u00f3n por VIH en Espa\u00f1a. 2023. Disponible en: http:\/\/.gesida-seimc.org\/category\/guias-clinicas\/otras-guias-vigentes\/."}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X25001777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X25001777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:21:33Z","timestamp":1778962893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X25001777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2529993X25001777"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2025.06.012","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SIPrEP: A tool to monitor HIV pre-exposure prophylaxis in Spain","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2025.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica.","name":"copyright","label":"Copyright"}]}}